Instructions for Rhinostop (Xylometazoline)
Indications Rhinostop:
Suppurative and unspecified otitis media
Acute sinusitis
Allergic rhinitis due to pollen
Other allergic rhinitis
Preparatory procedures for subsequent treatment, not elsewhere classified
Pharmacological group Rhinostop:
A vasoconstrictor drug for local use in ENT practice
pharmachologic effect Rhinostop:
A vasoconstrictor for topical use in ENT practice. Alpha adrenergic agonist. When applied to mucous membranes, it causes vasoconstriction, as a result of which local hyperemia and edema decrease. With rhinitis, it facilitates nasal breathing.
Pharmacokinetics Rhinostop:
When applied topically, it is practically not absorbed, plasma concentrations are so small that they cannot be determined by modern analytical methods.With frequent and / or prolonged use: irritation of the mucous membrane, burning, tingling, sneezing, dry nasal mucosa, hypersecretion.
Rarely: swelling of the nasal mucosa (more often with prolonged use), palpitations, cardiac arrhythmias, increased blood pressure, headache, vomiting, sleep disorders, visual impairment.
With long-term use in high doses: depression.
special instructions Rhinostop:
Should not be used for a long time, for example, in chronic rhinitis. For colds in cases where crusts form in the nose, it is preferable to prescribe in the form of a gel.
Use in pediatrics
is prescribed with caution to children under 2 years of age (gel - up to 7 years).
Application during pregnancy and lactation:
During pregnancy and lactation, it should be used only after a careful assessment of the risk-benefit ratio for the mother and the fetus, the recommended doses should not be exceeded.
Drug interactions
Incompatible with MAO inhibitors and tricyclic antidepressants.